Related Experiment Video

Updated: Oct 19, 2026

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression
08:58

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Published on: April 18, 2025

Cystic fibrosis: an inherited susceptibility to bacterial respiratory infections

B Tümmler1, C Kiewitz

  • 1Klinische Forschergruppe, Zentrum Biochemie und Zentrum Kinderheilkunde, OE 6711, Medizinische Hochschule Hannover, D-30623 Hannover, Germany. tuemmler.burkhard@mh-hannover.de

Molecular Medicine Today
|August 4, 1999
PubMed

Insights

Cystic fibrosis patients face chronic bacterial infections, particularly Pseudomonas aeruginosa. Current treatments improve outcomes, and vaccine research offers future hope for managing this genetic disorder.

Area of Science:

  • Medical Research
  • Genetics
  • Microbiology

Background:

  • Cystic fibrosis is a severe monogenic disorder affecting ion transport.
  • It leads to chronic bacterial airway infections, including Pseudomonas aeruginosa.
  • Pseudomonas aeruginosa in cystic fibrosis exemplifies bacterial adaptation in a host environment.

Purpose of the Study:

  • To discuss the challenges of Pseudomonas aeruginosa infections in cystic fibrosis.
  • To highlight the effectiveness of current antipseudomonal chemotherapy.
  • To mention ongoing research for cystic fibrosis vaccines.

Main Methods:

  • Literature review on cystic fibrosis and Pseudomonas aeruginosa.
  • Analysis of treatment strategies for Pseudomonas infections.
  • Overview of vaccine development in cystic fibrosis.

Main Results:

  • Pseudomonas aeruginosa infections are a significant complication in cystic fibrosis.
  • Aerosol and systemic antipseudomonal drugs have improved patient prognosis.
  • Vaccine research is progressing for cystic fibrosis.

Conclusions:

  • Pseudomonas aeruginosa infections in cystic fibrosis demonstrate bacterial adaptability.
  • Effective chemotherapy has improved disease management.
  • Future vaccines are anticipated to further enhance cystic fibrosis treatment.

More Related Videos

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections06:57

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections

Published on: May 8, 2017

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...